Pharm 2 Farm Update

RNS Number : 8931I
Remote Monitored Systems PLC
16 December 2020
 

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

16 December 2020

Remote Monitored Systems plc ("RMS" or the "Company")

Pharm 2 Farm Update

Remote Monitored Systems plc, announces the following updates in respect of its wholly owned subsidiary, Pharm2 Farm Limited ("P2F").

Receipt of new production line report

Further to the Company's announcement of Monday 14 December 2020, the Company has now received and reviewed the detailed report on the new production line. The report indicates certain areas of the line that require refinement prior to delivery, including the process by which the machine is adjusted for different input materials. These adjustments are expected to be completed during the next week alongside the final component finishing work noted in the Company's announcement of 11 December 2020.

Delivery of the Lemu mask making machine to Nottingham

In order to accommodate the adjustments noted above Lemu have advised of a further slight delay to the delivery of the machine. The finished machine will be ready to depart the manufacturers premises on 24th December 2020, the date of arrival in Nottingham is not known, the intention is of it being ready to commence operation by mid-January 2021.

The Company expects to provide a further update on expected production volumes once the machine has been commission and is operational in Nottingham.

 

 

 

- ENDS -

 

ENQUIRIES :

Remote Monitored Systems plc

John Richardson (Executive Director)  +44 7751 118916

 

SP Angel Corporate Finance LLP                                                                +44 20 3470 0470

Nominated Adviser and Joint Broker

Stuart Gledhill

Caroline Rowe

 

Peterhouse Corporate Finance   +44 20 7469 0930

Joint Broker

Lucy Williams

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDTFBITMTMBBFM
UK 100

Latest directors dealings